U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07134660) titled 'Thoracic Surgery Intercostal Block Trial With Liposomal vs. Hydrochloride Bupivacaine' on Aug. 03.
Brief Summary: This randomized controlled trial evaluates the analgesic effects of liposomal bupivacaine compared to bupivacaine hydrochloride in intercostal nerve block for patients undergoing thoracoscopic lung surgery. Postoperative pain remains a significant issue in thoracic procedures, often leading to complications like pneumonia or delayed recovery. The investigators hypothesize that liposomal bupivacaine, with its extended-release properties, will provide superior pain relief beyond 24 hours compared to standard bupivacaine or...